“…To detect radiotherapy-induced changes, MRI is generally considered as the most sensitive non-invasive technique with good clinical availability. Routine MRI techniques, such as T1-weighted imaging (T1), T2-weighted imaging (T2), fluid attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE), T2*-weighted gradient echo (T2*) and susceptibility-weighted imaging (SWI) can show oedema, cerebral microbleeds (CMBs), telangiectasias, cavernomas, white matter lesions (WML), lacunar infarcts, cortical atrophy and necrosis [13][14][15][16][17][18][19]. In the last decades, advanced imaging biomarkers reflecting microvascular integrity and function, such as quantitative susceptibility mapping (QSM), DSC-based (Dynamic Susceptibility Contrast-Enhanced) vessel architectural imaging (VAI), arterial spin labelling (ASL), diffusion tensor imaging (DTI), intravoxel incoherent motion (IVIM) have emerged [20][21][22][23][24][25].…”